Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for advanced oral cancer（Review Article）

Abstract

Extended surgery for patients with locally advanced oral cancer causes a marked loss of oral function, including swallowing and speech, and affects the quality of life. Retrograde superselective intra-arterial chemotherapy can be used to provide daily concurrent chemoradiotherapy for patients with oral cancer. We evaluated the therapeutic results and the rate of organ preservation in patients with advanced oral cancer treated with intra-arterial chemoradiotherapy. This treatment provides good overall survival and local control rates for patients with advanced oral cancer.
In this review, we introduce the therapeutic results in patients with advanced oral cancer treated with retrograde superselective intra-arterial chemoradiotherapy.